EP3151853
Glútamínsýrudekarboxílasi (GAD) til að nota við að meðhöndla sjálfsónæmissjúkdóm
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.6.2015EP published:
6.5.2020EP application number:
15802815.9
EP translation filed:
7.7.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
3.6.2035Expiry date:
3.6.2026Next due date:
30.6.2026
Title:
GLUTAMIC ACID DECARBOXYLASE (GAD) FOR USE IN THE TREATMENT OF AN AUTOIMMUNE DISEASE
Timeline
Today
4.6.2015EP application
6.5.2020EP Publication
7.7.2020Translation submitted
15.8.2020Registration published
3.6.2026Expires
Owner
Name:
Diamyd Medical ABAddress:
Kungsgatan 29, 111 56 Stockholm, SE
Inventor
Name:
ESSEN-MÖLLER, AndersAddress:
S-111 56 Stockholm, SE
Name:
LUDVIGSSON, JohnnyAddress:
S-581 83 Linköping, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
1450678Date:
4.6.2014Country:
SE
Number:
1451315Date:
4.11.2014Country:
SE
Classification
Categories:
A61K 38/51, A61K 39/00, A61K 31/592, A61K 31/593, A61P 37/06, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 21.7.2020
Expires: 3.6.2021
Payer: Zacco Denmark A/S
Number: 7
Paid: 31.5.2021
Expires: 3.6.2022
Payer: Zacco Denmark A/S
Number: 8
Paid: 10.5.2022
Expires: 3.6.2023
Payer: Zacco Denmark A/S
Number: 9
Paid: 11.5.2023
Expires: 3.6.2024
Payer: Zacco Denmark A/S
Number: 10
Paid: 30.5.2024
Expires: 3.6.2025
Payer: Zacco Denmark A/S
Number: 11
Paid: 21.5.2025
Expires: 3.6.2026
Payer: Zacco Denmark A/S